| N = 480 |
---|---|
Demographics | Â |
Sex (n,% female) | 347 (72.3) |
Age (mean, SD) | 59.0 (13.0) |
Traditional CV risk factors | Â |
Smoking, current (n,%) | 114 (23.8) |
Systolic blood pressure (mmHg, mean, SD) | 144.0 (22.9) |
Total cholesterol (mmol/L, SD) | 5.3 (0.99) |
LDL cholesterol (mmol/L, SD) | 3.1 (0.83) |
Triglycerides (mmol/L, SD) | 1.3 (0.65) |
Atherogenic index (mean, SD) | 3.7 (1.1) |
GlyHb (%, mean, SD) | 5.8 (0.67) |
SCORE 10-year estimated CV risk (%, SD)) | 5.7 (4.9) |
Inflammatory markers | Â |
ESR (mm/hr, mean, SD) | 16.5 (14.9) |
Hs CRP (mg/L, mean, SD) | 7.0 (10.0) |
RA disease characteristics | Â |
RA disease duration (years; median, 25th-75th percentile) | 4.2 (1.5-11.3) |
Seropositive (anti-CCP and/or IgMRF; n,%) | 286 (63.3) |
Erosions (n,%) | 198 (42.2) |
DAS 28 (mean, SD) | 2.5 (1.2) |
Remission (n,%) | 223 (72.1) |
Medication | Â |
DMARD (n,%) | 350 (72.9) |
MTX (n,%) | 291 (60.6) |
TNFα inhibitor (n,%) | 105 (21.9) |
NSAID (n,%) | 177 (36.9) |
Corticosteroids (n,%) | 68 (14.2) |